Role of Vitamin D in the Metabolic Syndrome
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
The prevalence of hypovitaminosis D has risen in developed countries over the past few years in association with lifestyle changes and an increase in unhealthy habits. Vitamin D deficiency has been implicated in various diseases, including metabolic syndrome (MetS), which is clinically defined by a set of metabolic and vascular disorders. The objective of this study was to review scientific evidence on the relationship between MetS and vitamin D deficiency to support the development of prevention strategies and health education programs. An inverse relationship has been reported between plasma vitamin D concentrations and the features that define MetS, i.e., elevated serum concentrations of glucose, total cholesterol, low-density lipoproteins, triglycerides, glycosylated hemoglobin, and a high body mass index. Numerous studies have described the benefits of vitamin D supplementation to improve outcomes in individuals with MetS. Interventions to maintain optimal vitamin D concentrations are proposed as a preventive strategy against MetS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Global Epidemic of the Metabolic Syndrome
Saklayen, M. G. (2018) · Current Hypertension Reports · doi:10.1007/s11906-018-0812-z · Cited by 3,990
Comment on the provisional report from the WHO consultation
(1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00059.x · Cited by 1,820 · cited 1×
“consensus agreements [1,2,3] and currently comprise central (intraabdominal) obesity,”
BackgroundVimaleswaran, K. S., Berry, D. J., Lu, C., Tikkanen, E., Pilz, S., Hiraki, L. T., Cooper, J. D., Dastani, Z., Li, R., Houston, D. K., et al. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001383 · Cited by 1,046
Lemieux, P., Weisnagel, S. J., Caron, A. Z., Julien, A.-S., Morisset, A.-S., Carreau, A.-M., Poirier, J., Tchernof, A., Robitaille, J., Bergeron, J., et al. (2019) · European Journal of Endocrinology · doi:10.1530/eje-19-0156 · Cited by 102
Safarpour, P., Daneshi-Maskooni, M., Vafa, M., Nourbakhsh, M., Janani, L., Maddah, M., Amiri, F.-S., Mohammadi, F., & Sadeghi, H. (2020) · BMC Family Practice · doi:10.1186/s12875-020-1096-3 · Cited by 100 · cited 2×
“[50] 2020 50,000 IU/week vitamin D (Zahravi Co® pearls), 8 weeks Vitamin D supplementation improved T2D by decreasing HbA1c and increasing SIRT1.”
BackgroundJamilian, M., Samimi, M., Ebrahimi, F. A., Hashemi, T., Taghizadeh, M., Razavi, M., Sanami, M., & Asemi, Z. (2017) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2017.01.011 · Cited by 96 · cited 2×
“[56] 2017 50,000 IU vitamin D every 2 weeks + 1000 mg omega-3 fatty acids twice a day, 6 weeks Overall, vitamin D and omega-3 fatty acids co-supplementation for 6 weeks among gestational diabetes patients had beneficial effects on fasting plasma glucose, serum insulin levels, the homeostatic model of assessment for in…”
BackgroundMethodLerchbaum, E., Trummer, C., Theiler-Schwetz, V., Kollmann, M., Wölfler, M., Pilz, S., & Obermayer-Pietsch, B. (2019) · Nutrients · doi:10.3390/nu11081894 · Cited by 29 · cited 2×
“further claimed that vitamin D treatment might have a negative effect on insulin sensitivity in healthy men [54].”
Background
Cited by
The Role of Maternal Vitamin D Deficiency in Offspring Obesity: A Narrative Review
Wu, Y., Zeng, Y., Zhang, Q., & Xiao, X. (2023) · Nutrients · doi:10.3390/nu15030533 · Cited by 24
Metadata
- Authors
- Melguizo-Rodríguez, L., Costela-Ruiz, V. J., García-Recio, E., De Luna-Bertos, E., Ruiz, C., & Illescas-Montes, R.
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2021-03-03
- Volume
- 13
- Issue
- 3
- Pages
- 830
- ISSN
- 2072-6643 (ISSN-L)
- OpenAlex
- W3134057509
- Cited by
- 163
- References
- 7
- FWCI
- 15.62
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.